Yes, or No? Is there an effect of leukemia drugs on bacteria isolated from different sites of ALL and AML patients?
DOI:
https://doi.org/10.52783/jns.v14.3351Keywords:
Acute leukemia, gram-positive, gram-negative bacteria, Cytarabine, Decitabine, procalcitonin, C reactive proteinAbstract
Objective: The current research aims to evaluate the prevalence of causative bacterial species in acute myeloid and lymphoblastic leukemia patients, as well as the effect of certain chemotherapeutic agents on the growth of common bacterial pathogens isolated from various sites in these patients. Additionally, it investigates the relationship between elevated minimum inhibitory concentrations (MICs) of chemotherapeutic drugs and antimicrobial resistance.
Methods: This study included 200 patients who attended HTC in Medical City during a period between October 2023 to January 2024, ranging in age from 14 to 81 years. Blood, urine, sputum and swab samples were collected from various sites, including skin and throat swabs. The isolates were identified through phenotypic examination and biochemical tests, and confirmed by VITEK-2 assay. Antibiotic susceptibility pattern and the ability to form biofilms were studied for all bacterial isolates, followed by MIC testing for chemotherapeutic drugs including Cytarabine and
Decitabine.
Results: Statistical analysis indicated significant differences (p ≤ 0.05) in age between ALL and AML patients with and without fever notable discrepancies were observed in the age groups of both ALL and AML patients. While highly significant differences were indicated a distribution of 195 isolates into gram-positive and gram-negative categories, no significant correlation was observed between the type of bacteria and their sources .Synergistic effects were detected among certain antibiotics against bacteria isolated from various sources. Comparing groups revealed significantly higher differences in PCT concentration associated with both ALL and AML with fever when considering bacterial group .Also significant distinction was recorded among the analyzed groups of gram-positive and gram-negative bacterial isolates in ALL and AML patients concerning the mean concentration of CRP. No inhibitory effects were noticed across all minimum inhibitory concentration (MIC) values for both chemotherapy agents Cytarabine and Decitabine towards various multidrug-resistant bacterial isolates obtained from different sources.
Downloads
Metrics
References
Hansen B.A., Wendelbo Ø., Bruserud Ø., Hemsing A.L., Mosevoll K.A. and Reikvam H. 2020. Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment. Mediterranean Journal of Hematology and Infectious Diseases. 12: 1.
Aljamali N M., Obaid A J. and Naser M. S.2021. Chemical Causes of Leukemia. Journal of Modern Chemistry & Chemical Technology.12:3 DOI (Journal): 10.37591/JoMCCT
Grimwade, D., Ivey, A., & Huntly, B. J. 2016. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood, 127(1), 29–41. https://doi.org/10.1182/blood-2015-07-604496
Cortes J.E. and Kantarjian H.M. 1995. Acute lymphoblastic leukemia a comprehensive review with emphasis on biology and therapy. Cancer.76:12. (2393-2417).
Fey M.F. 2007. Salient features of hematological diseases. Annals of Oncology.18:(i54-i64).
Yusuf K., Sampath V. and Umar S. 2023. Bacterial infections and Cancer: Exploring this Association and its implications for Cancer patients. International Journal of Molecular Sciences. 24: 4. (.3110).
Aslaner Ak M.A. and Haciseyitoglu D. 2023. The Effect of Bacterial Pathogens Isolated from Blood Cultures on Prognosis in Febrile Neutropenia in Hematological Malignancies. Eurasian Journal of Medical Investigation 7:1.
Shabeeb, D.B.; Naji, E.N. 2023 Prevalence of parallel infection of dental caries and tonsillitis among some Iraqi children. Revis Bionatura; 8 (1) 84.
Mjali A, Al Baroodi BNH, Alharganee A. 2021. A Pattern of Bacterial Infections in Acute Leukemia Patients with Neutropenic Fever in Middle Euphrates Region of Iraq. International Journal of Drug Delivery Technology.11: 2. (248-251).
Yang M., Choi S.J., Lee J., Lee D.G., Kim Y.J., Park Y.J. and Oh E.J. 2019. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies. PLoS One. 14: 12. (e0225765).
Qasim A.J., Naji E.N. and Brakhas S.A. 2023. Procalcitonin, C-reactive protein, ferritin and interleukin-37 levels among COVID-19 patients in the presence or absence of secondary bacterial infections. Reviews and Research in Medical Microbiology. 34: 4 (196-200).
Cruz-Muñiz, M. Y., López-Jacome, L. E., Hernández-Durán, M., Franco-Cendejas, R., Licona-Limón, P., Ramos-Balderas, J. L., Martinéz-Vázquez, M., Belmont-Díaz, J. A., Wood, T. K., & García-Contreras, R. 2017. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections. International journal of antimicrobial agents, 49(1), 88–92.
Kantarjian H.M., Thomas X.G., Dmoszynska A., Wierzbowska A., Mazur G., Mayer J., Gau J.P., Chou W.C., Buckstein R., Cermak J. and Kuo C.Y. 2012. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. Journal of Clinical Oncology. 30: 21. (2670).
Murray P.R., Rosenthal K.S. and Pfaller M.A. 2020. Medical microbiology E-book. Elsevier Health Sciences 9: (426-433).
Brooks G.F., Carroll K.C., Butel J.S., Morse S.A. and Mietzner T.A. 2013. Medical Microbiology. 26th edit. New York: McGraw-Hill.
CLSI. 2021. Performance standards for antimicrobial susceptibility testing, M100, 31st ed. Clinical and Laboratory Standards Institute, Wayne, PA.
Edwar D.A., Naji E.N. and Maleki A. 2023. Biofilm And Hemolysis Profile Index in Bacteria Isolated from Pre-Cesarean Surgery and Post Cesarean Infections. Al-Mustansiriyah Journal of Science. 34: 4. (8-18).
Fiegl, M. (2016). Epidemiology, pathogenesis, and etiology of acute leukemia. In Handbook of Acute Leukemia (pp. 3–13). Springer International Publishing. https://doi.org/10.1007/978-3-319-26772-2_2
Appelbaum F R, Gundacker H, Head R D,et al .2006. Age and acute myeloid leukemia. BLOOD. 107(9).
Majid H., Masoom M., Bansal N., Ahmad W., Khan M.F., Farooqui S., Bhurani D. and Khan M.A. 2024. Spectrum of infections in different regimens of post-induction chemotherapy in acute myeloid leukemia (de-novo): A comparative retrospective study. Heliyon. 10:3.
Abedelnasser S.I., Mohamed H.F. and Zahran A.M., 2020. Bloodstream bacterial infection in neutropenic acute leukemia patients. Journal of Cancer Therapy 11:5 (296-305).
Abdulhussein A N(2022).A Study of Bacteremia in Patients with Acute Leukemia. Appelbaum F R, Gundacker H, Head R D,et al (2006). Age and acute myeloid leukemia. BLOOD. 107(9).
Amanati A., Sajedianfard S., Khajeh S., Ghasempour S., Mehrangiz S., Nematolahi S. and Shahhosein Z. 2021. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BioMed Cental infectious diseases 21. (1-14).
Alevizakos, M., Karanika, S., Detsis, M., & Mylonakis, E. 2016. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. International journal of antimicrobial agents, 48(6), 647–654. https://doi.org/10.1016/j.ijantimicag.2016.08.021 .
Edwar D.A., Naji I.N. and Aboul-Ela H.M. 2023. Investigation the Role of Various Antiseptics on the Prevalence of Skin Microbiota and Post Cesarean Surgery Infections. Al-Mustansiriyah Journal of Science. 34: 3. (1-9).
Tumbarello, M., Trecarichi, E. M., Bassetti, M., De Rosa, F. G., Spanu, T., DiMeco, E., Losito, A. R., Parisini, A., Pagani, N., & Cauda, R. (2011). Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrobial agents and chemotherapy, 55(7), 3485–3490. https://doi.org/10.1128/AAC.00009-11
Al-Kadmy IMS, Abid SA, Aziz SN, Al-Kadmy Z, Suhail A, Al-Jubori SS, Naji EN, Alhomaidi E, Yahia R, Algammal AM, Batiha GE, Hetta HF. The secrets of environmental Pseudomonas aeruginosa in slaughterhouses: Antibiogram profile, virulence, and antibiotic resistance genes. Folia Microbiol (Praha). 2023 Dec 13.
De Rosa, F. G., Motta, I., Audisio, E., Frairia, C., Busca, A., Di Perri, G., & Marmont, F. (2013). Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis. BMC infectious diseases, 13, 563. https://doi.org/10.1186/1471-2334-13-563
Awayid, H.S., Esaa, R.H., Naji, E.N., Jasem, M.A.2017. The innovative method for vaccine preparation against multidrug resistant and virulence acinetobacter baumannii Iraqi isolates .Baghdad Science Journal.14(4), pp. 717–72
Ashour, H. M., & el-Sharif, A. (2007). Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25(36), 5763–5769. https://doi.org/10.1200/JCO.2007.14.0947
Perdikouri, E. I. A., Arvaniti, K., Lathyris, D., Apostolidou Kiouti, F., Siskou, E., Haidich, A. B., & Papandreou, C. (2019). Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis. Microorganisms, 7(9), 277. https://doi.org/10.3390/microorganisms7090277
Edwar, Dalia Awni; Naji, Eman Natiq. Association between various antiseptics and multidrug-resistant skin microbiota and post-cesarean surgery infection. Reviews and Research in Medical Microbiology ():10.1097/MRM.0000000000000377, October 17, 2023. | DOI: 10.1097/MRM.0000000000000377
Yan S.T., Sun L.C., Jia H.B., Gao W., Yang J.P. and Zhang G.Q. 2017. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. The American Journal of Emergency Medicine. 35: 4. (579-583).
Soo, V. W., Kwan, B. W., Quezada, H., Castillo-Juárez, I., Pérez-Eretza, B., García-Contreras, S. J., Martínez-Vázquez, M., Wood, T. K., & García-Contreras, R. (2017). Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections. Current topics in medicinal chemistry, 17(10), 1157–1176. https://doi.org/10.2174/1568026616666160930131737
Montassier, E., Gastinne, T., Vangay, P., Al-Ghalith, G. A., Bruley des Varannes, S., Massart, S., Moreau, P., Potel, G., de La Cochetière, M. F., Batard, E., & Knights, D. 2015. Chemotherapy-driven dysbiosis in the intestinal microbiome. Alimentary pharmacology & therapeutics, 42(5), 515–528. https://doi.org/10.1111/apt.13302
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
